67 results
8-K
EX-99.2
IVVD
Invivyd Inc
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
: At-the-market; COGS: cost of goods sold; R&D: Research and development 7
Q&A 8
T H A N K YO U !
8-K
EX-99.1
IVVD
Invivyd Inc
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
to fund its operating expenses and capital expenditure requirements into the fourth quarter of 2024.
Research & Development (R&D) Expenses (including … In-Process Research & Development): R&D expenses were $163.6 million for the year ended December 31, 2023, compared to $183.6 million for year ended
8-K
EX-99.1
0o346
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
EX-99.1
34zdlr9831e0
8 Jan 24
Other Events
7:12am
8-K
EX-99.1
ujzdib8v1g
3 Jan 24
Other Events
7:06am
424B5
768i 8fazfu
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.1
5iew 1w4ss4
18 Dec 23
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial
7:16am
8-K
EX-99.1
9bzvaci
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm
8-K
EX-99.1
2qnl fkucp6
11 Sep 23
Other Events
7:10am
8-K
EX-99.1
3d4cr
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
8-K
EX-99.1
kv78y
10 Aug 23
Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
EX-99.1
ftfqfigrl5e
27 Jul 23
Invivyd Announces Appointment of Sara Cotter to Board of Directors
4:06pm
8-K
EX-99.1
uurtcz b43jc5z
29 Jun 23
Other Events
7:08am
8-K
EX-99.1
ixwvrv1 iqc
11 May 23
Invivyd Reports First Quarter 2023 Financial Results and Business Highlights
4:08pm